PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, and 47 other peptide genes across 14 metabolic pathways, revealing your baseline GLP-1 receptor sensitivity and gastrointestinal response patterns
[1] [8] Phase 2 trial data published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated substantial reductions in body weight with retatrutide, and Phase 3 trials are currently registered and under way (ClinicalTrials.gov)
This blood sugar rise can result in the same damaging consequences as in type 1 diabetes, including cardiovascular disease, kidney failure, and early death
One participant had not had an HbA 1c measurement at follow-up
Benefits of GLP-1 Agonists Effective Weight Loss: Significant weight reduction, with some patients losing 15-25% of their body weight
A fast-absorbing protein that immediately supplies muscles with amino acids and supports recovery